ClinicalTrials.Veeva

Menu

The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension. (PAH)

N

National Defense Medical Center, Taiwan

Status

Enrolling

Conditions

Web-based Health Care Program

Treatments

Other: Web-based health care program

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Pulmonary arterial hypertension (PAH) is a chronic disease characterized by an elevation in pulmonary artery pressures and pulmonary vascular resistance. The condition most often is rarely detected, and patients frequently suffer symptoms for several years before being appropriately diagnosed. Patients with PH suffer from several symptoms, such as exertional dyspnea, fatigue, weakness, chest pain, fainting...et al. Pulmonary hypertension is an incurable and progressive disease with complex symptoms and treatments. Patients must learn to deal with their unpredictable future and manage the complex treatments associated with severe adverse effects and need significant changes in lifestyle.

Therefore, it is important to assist patients to develop the ability of symptom management.

Enrollment

100 estimated patients

Sex

All

Ages

20 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. At least 20 years old, diagnosed by clinical specialists as patients with pulmonary hypertension (Group1 and Group 4)
  2. Clear consciousness, able to communicate in Mandarin and Taiwanese, with normal hearing
  3. Those who have internet or mobile internet at home
  4. Adults without mental illness
  5. No alcohol or drug abusers.

Exclusion criteria

  1. critical disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Web-based health care program
Experimental group
Description:
We aim to develop a PAH web-based health care program, and to evaluate the effects of this program on ameliorating social support, self-care ability and active tolerance, and improving symptom distress, anxiety, depression and quality of life in patients with PAH.
Treatment:
Other: Web-based health care program
Usual care
No Intervention group
Description:
usual care

Trial contacts and locations

1

Loading...

Central trial contact

Chen miao-yi, PhD Stusent

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems